Видео с ютуба Access To Medicine

Access to Medicine: An Expert View of What It Means and Why It Matters

Creating impact: Access to Medicine Foundation

Jayasree K. Iyer | Access to Medicine and Healthcare | Frontiers Forum 2019

Access to Medicine

What is the industry doing to improve access to diabetes care for children and young people?

Bill Gates on the significance of the Access to Medicine Index at the 2018 WEF, Davos

ACCESS TO MEDICINE - I Answer Your Questions! / Mature Medical Student

What are generic & biosimilar medicine manufacturers doing to expand access to their products?

Dr Linda-Gail Bekker on what more can companies do to scale up access

An interview with Mariângela Simão, Director-President of the Instituto Todos pela Saúde

Access to Medicine Foundation's CEO, Jayasree K. Iyer: Join us in taking access to the next level

Bill Gates explains the importance of the Access to Medicine Index at the Clinton Foundation

An interview with Dr Claus Runge, Bayer Pharmaceuticals

How can generic and biosimilar medicine manufacturers scale up access to medicine?

An interview with Esteban Burrone, Head of Policy, Strategy and Market Access at MPP

Danny Edwards (Access to Medicine Foundation): Considerations for sustainable access

McGraw Hill AccessMedicine® Overview

An interview with Dr Iain Barton, Founding Principal of Health 4 Development

Webinar | Leveraging the 2024 Access to Medicine Index for Equitable Healthcare

Why is it important to improve access to medicine in the UK?

Medicine for All: The Role of the Pharmaceutical Industry in Providing Access to Medicine in LMICs

Understanding the Access to Medicine Index and its methodology

Fireside chat on the role of generic and biosimilar medicine manufacturers in scaling up access

Clarke Cole (Access to Medicine Foundation): The new Access to Vaccines Index

2024 Access to Medicine Index: A deep dive with the Foundation's CEO, Jayasree K. Iyer